EBS · —

BB Biotech AG (BION.SW) Stock

$53.20 +3.30% EBS: BION.SW —

BB Biotech AG is an investment fund overseen by Bellevue Asset Management AG. This fund allocates capital to publicly traded companies worldwide, with a primary focus on firms pioneering modern biotechnology, specifically in the development of medications and diagnostic tools.

Valuation

MetricValue
Price$53.20
Market Cap—
P/E Ratio—
P/B Ratio—
P/S Ratio—
EPS (TTM)—
52-Week High$53.40
52-Week Low$30.75
Dividend Yield—

Financials & Margins

MetricValue
ROE—
ROA—
ROCE—
Gross Margin—
Operating Margin—
Net Margin—
Debt/Equity—
Current Ratio—

Latest News

Netcompany upgrade revenue guidance for full year 2026 GlobeNewswire · Aug 13, 2026 5 Must-Read Analyst Questions From TransDigm’s Q2 Earnings Call StockStory · Aug 13, 2026 Billionaire Ken Griffin Said an AI System at Citadel Reproduced 8 Weeks of Ph.D.-Level Research in 2 Hours. He Now Believes AI Will Spark a "Golden Age" of Entrepreneurship. Motley Fool · Aug 13, 2026 PLUG Q2 Deep Dive: Margin Gains and Cost Discipline, Guidance Raised StockStory · Aug 13, 2026 BYD (SEHK:1211), What Is The Latest Update Really Telling Investors? Simply Wall St. · Aug 13, 2026

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield—
Quick Ratio—
Interest Coverage—
Return 1Y79.84%
Return 3Y47.81%
Return 5Y-21.37%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ADXN.SWAddex Therapeutics Ltd $0.04 +0.00% — — 0.00%
BSLN.SWBasilea Pharmaceutica AG $52.60 +2.33% — — 0.00%
EVE.SWEvoNext Holdings SA $2.08 -3.26% -23.11 $15.00M 0.00%
IDIA.SWIdorsia Ltd $6.73 +3.38% 121.66 $1.78B 0.00%
KURN.SWKuros Biosciences AG $23.00 -0.17% — — 0.00%

About BB Biotech AG

BB Biotech AG is an investment fund overseen by Bellevue Asset Management AG. This fund allocates capital to publicly traded companies worldwide, with a primary focus on firms pioneering modern biotechnology, specifically in the development of medications and diagnostic tools. The construction of its investment portfolio is guided by a fundamental analysis approach. Established on November 9, 1993, BB Biotech AG is headquartered in Switzerland.

BB Biotech AG is led by CEO Daniel Koller, employs 10 people, headquartered in Kusnacht, CH, publicly traded since 1993.

over the past 52 weeks the stock has ranged between $30.75 and $53.40, and currently trades at its 52-week high.

Official website: www.bbbiotech.ch/ch-en/private

Related — Stocks

BNY — $152.52 -2.54% CIEN — $412.39 +2.14% CBRS — $188.61 -5.28% HEI.A AIRCRAFT ENGINES & ENGINE PARTS $216.35 +0.00% LEN.B GENERAL BLDG CONTRACTORS - RESIDENTIAL BLDGS $80.32 +0.00% WSO.B WHOLESALE-HARDWARE & PLUMBING & HEATING EQUIPMENT & SUPPLIES $453.37 +0.00% MKC.V MISCELLANEOUS FOOD PREPARATIONS & KINDRED PRODUCTS $51.78 +0.00% MOG.B MISC INDUSTRIAL & COMMERCIAL MACHINERY & EQUIPMENT $322.00 +0.00% MOG.A MISC INDUSTRIAL & COMMERCIAL MACHINERY & EQUIPMENT $307.91 +0.00% UHAL.B SERVICES-AUTO RENTAL & LEASING (NO DRIVERS) $45.71 +0.00% TAP.A MALT BEVERAGES $47.89 +0.00% VSXY — $88.68 +0.50%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens featuring this stock

High ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksAll stock screens
Run Stock Screener Investing Guides